CYP 0.00% 20.5¢ cynata therapeutics limited

9 Sept Interview BioInformant Dr Macdonald, page-3

  1. 307 Posts.
    lightbulb Created with Sketch. 248
    Over expansion of MSCs in culture causes senescence (the condition or process of deterioration with age. loss of a cell's power of division and growth). A fairly recent and ever growing body of literature can attest to this.

    TEMCELL and all other first-generation methods of manufacturing (bone-marrow MSCs etc) have proved that MSCs work (thanks to all who paved the way!), but they cannot produce enough potent and consistent cells on an industrial commercial scale.

    https://hotcopper.com.au/threads/in...3595554/page-44?post_id=26539938#.WbzPctOg9zk

    No CR on the horizon.... cash runway deep into second half of 2018.

    Excellent results from PoC Asthma studies. Which Pharma is lurking in the background?

    FOMO will kick-in soon and this will smash through a $1.50 by Christmas.

    The growth potential of this stock is ENORMOUS.



    $300-500mill MC (but worth $1bn+... )
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
20.5¢
Change
0.000(0.00%)
Mkt cap ! $37.01M
Open High Low Value Volume
20.5¢ 20.5¢ 20.5¢ $3.171K 15.47K

Buyers (Bids)

No. Vol. Price($)
1 36753 20.5¢
 

Sellers (Offers)

Price($) Vol. No.
21.5¢ 235 1
View Market Depth
Last trade - 12.04pm 15/08/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.